Webinar : Advances in cardiovascular diagnostic devices for clinical trial
Tuesday, May 29th, 2018
6:00 PM CEST (Central European Time) UTC/GMT + 2 hours
Duration: 1 hour
Paul Dorian – MD, PhD – Division of Cardiology at University of Toronto
Etienne Aliot – MD, PhD – Chief Medical Officer Banook Group
Novel smart cardiac monitoring technologies for Clinical Trials: a state-of-art review.
The increasing popularity of new biosensors has opened up several opportunities for the management of cardiac end points during clinical trials. The purpose of this presentation is to assess the role and utility of these novel technologies in the cardiac safety and rhythm assessment. The lecture will cover the benefits and constraints of implanted devices, wearable sensors, connected devices…including the added value of patient friendly diagnostics systems.
How to deal with Wearables Cardiac Biosensors in Clinical Trials? Two practical uses cases.
This presentation will assess the (im)possibilities and design of clinical trials that intent to use wearable cardiac biosensor as method of choice for safety or Atrial Fibrillation assessment. Two concrete uses cases will be covered including the use of a mobileECG heart monitor and a long-term cable-free ECG recording system.
Professor Paul Dorian is the Department Director, Division of Cardiology, University of Toronto and Staff Cardiac Electrophysiologist at St. Michael’s Hospital. He is Professor of Medicine in the Division of Cardiology and in the Division of Clinical Pharmacology at the University of Toronto, and a Staff Scientist at the Li Ka Shing Knowledge Institute. His research interests include basic science research in advanced cardiac life support and atrial fibrillation, the clinical pharmacology of antiarrhythmic drugs, and clinical research on implanted devices, antiarrhythmic drugs, and quality of life in patients with arrhythmias.
Professor Etienne Aliot is the former head of the “Cardio Medico Surgical Center” of the University hospital of Nancy (France). He has extensive experience in scientific, clinical and regulatory aspects of cardiology practice acting as chairman of the Working Group on Arrhythmias of the European Society of Cardiology and Member of the Board the French Federation of Cardiology. He has participated in several scientific committee or DSMB of major randomized controlled trials.
To know more about Banook Group : http://www.banookgroup.com